相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combined PET-CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapy
B. B. Koolen et al.
BRITISH JOURNAL OF SURGERY (2017)
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial
Armando E. Giuliano et al.
ANNALS OF SURGERY (2016)
Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance)
Judy C. Boughey et al.
ANNALS OF SURGERY (2016)
Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes
Emilia J. Diego et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Is PET/CT Necessary in the Management of Early Breast Cancer?
Gul Nihal Nursal et al.
CLINICAL NUCLEAR MEDICINE (2016)
Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection
Abigail S. Caudle et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Staging PET-CT Scanning Provides Superior Detection of Lymph Nodes and Distant Metastases than Traditional Imaging in Locally Advanced Breast Cancer
Pankaj Kumar Garg et al.
WORLD JOURNAL OF SURGERY (2016)
Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy
Sarah S. Mougalian et al.
JAMA ONCOLOGY (2016)
Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials
Raquel F. D. van la Parra et al.
BREAST CANCER RESEARCH (2016)
Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy
Nurhan Ergul et al.
ACTA RADIOLOGICA (2015)
Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer Patients The MARI Procedure
Mila Donker et al.
ANNALS OF SURGERY (2015)
Long-term outcomes among breast cancer patients with extensive regional lymph node involvement: implications for locoregional management
Lior Z. Braunstein et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: A systematic review and meta-analysis
T. J. A. van Nijnatten et al.
EJSO (2015)
Noninvasive nodal restaging in clinically node positive breast cancer patients after neoadjuvant systemic therapy: A systematic review
R. J. Schipper et al.
EUROPEAN JOURNAL OF RADIOLOGY (2015)
Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance)
Judy C. Boughey et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy
Tari A. King et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer
Birgitte V. Offersen et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Tumor Biology Correlates With Rates of Breast-Conserving Surgery and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer Findings From the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial
Judy C. Boughey et al.
ANNALS OF SURGERY (2014)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
Mila Donker et al.
LANCET ONCOLOGY (2014)
Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group
Mette H. Nielsen et al.
ACTA ONCOLOGICA (2013)
Pre-chemotherapy 18F-FDG PET/CT upstages nodal stage in stage II-III breast cancer patients treated with neoadjuvant chemotherapy
Bas B. Koolen et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer The ACOSOG Z1071 (Alliance) Clinical Trial
Judy C. Boughey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis
Tracey DiSipio et al.
LANCET ONCOLOGY (2013)
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
Thorsten Kuehn et al.
LANCET ONCOLOGY (2013)
18FDG PET-CT for diagnosis of distant metastases in breast cancer patients. A meta-analysis
Shikai Hong et al.
SURGICAL ONCOLOGY-OXFORD (2013)
Effectiveness of multi-detector row computed tomography in detection of the presence and extent of ductal carcinoma in situ
Izo Kimijima et al.
BREAST CANCER (2013)
Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients
Carolin Riegger et al.
ACTA RADIOLOGICA (2012)
18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques
Bas B. Koolen et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy
Bas B. Koolen et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Radioactive Seed Localization of Breast Lesions: An Adequate Localization Method without Seed Migration
Tanja Alderliesten et al.
BREAST JOURNAL (2011)
Axillary Staging in the Neoadjuvant Setting
Alice Chung et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer
M. E. Straver et al.
BRITISH JOURNAL OF SURGERY (2010)
Cytologically Proven Axillary Lymph Node Metastases Are Eradicated in Patients Receiving Preoperative Chemotherapy With Concurrent Trastuzumab for HER2-Positive Breast Cancer
Laura S. Dominici et al.
CANCER (2010)
Morbidity Results From the NSABP B-32 Trial Comparing Sentinel Lymph Node Dissection Versus Axillary Dissection
Takamaru Ashikaga et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
Priya Rastogi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score
Eugene H. Huang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy
BT Hennessy et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
分享论文
